LLC PHARMASYNTEZ-TYUMEN

The Pharmasyntez-Tyumen plant was established in 2015.

In addition to the Liquid Dosage Form Department, Pharmasyntez-Tyumen also launched a Solid Dosage Form Department in 2016, where the production of sugar-reducing medications was started.

In November 2018, the Pharmasyntez-Tyumen plant was listed in the Russia's National Registry of Top Industrial Companies.

Pharmasyntez-Tyumen LLC and the Tyumen Region Administration agreed to build two additional departments for producing hormone drugs as well as a sizable warehousing facility in 2018.

On the basis of Pharmasyntez-Tyumen LLC, an investment project to construct a high-tech plant for the production of hormonal, and radiopaque drugs was implemented in 2022.

The launched production of hormone-based medications, which is unrivalled in Russia, aspires to rank among the biggest in Europe.

The Pharmasyntez-Tyumen plant currently focuses on producing antibacterial, hypoglycemic, antiretroviral, radiopaque, immunosuppressive, and hormonal medications, including combination oral contraceptives.

The Tyumen plant is the sole Russian manufacturer of the innovative anti-diabetic medication Saterex and fludrocortisone, which is sold under the brand name Ziflucort.

Most of the medicines that are produced are on the VED list.

The overall number of ALL registered pharmaceuticals is 83, which includes 24 trade names for medications used for hormone replacement therapy, oral contraceptive, and the treatment of gynecological conditions associated with endocrine disruption.

31.3 million packs worth of products from own production were shipped in 2022.

A total of 54 types of medications, including 17 hormonal medications, were produced in 2022.

The company produces 100,000 packs of solid dosage forms and 35,000 vials of liquid dosage forms per day.

Monthly production of hormonal medications totals 500,000 packs.

The R&D lab is expected to open in 2024, along with improvements to the plant's grounds and the reconstruction of the Solid Dosage Form Department and section used to produce soft gelatin capsules.